Cargando…

Cost-Effective Screening for Trichomoniasis—reply to Dr. Schwebke

Detalles Bibliográficos
Autores principales:	Sorvillo, Frank, Smith, Lisa, Kerndt, Peter
Formato:	Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2002
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730322/ http://dx.doi.org/10.3201/eid0807.020116

Ejemplares similares

Cost-Effective Screening for Trichomoniasis
por: Schwebke, Jane R.
Publicado: (2002)

Trichomoniasis: Is it always sexually transmitted?
por: Kandamuthan, Subitha, et al.
Publicado: (2014)

Dr Epenetos replies
por: Epenetos, A.A.
Publicado: (1986)

Dr. Andrade replies
por: Andrade, Chittaranjan
Publicado: (1996)

Reply from Dr. Shailendra Verma
por: Verma, Shail
Publicado: (2006)

Reply to Letter from Dr. Tokudome
por: Sugimura, Takashi
Publicado: (1989)

Reply to the Letter to the Editor by Dr. Chirumbolo
por: Won, Dong Il
Publicado: (2016)

Dr. Loades and Prof. Reynolds Reply
por: Loades, Maria Elizabeth, et al.
Publicado: (2021)

Dr. Macqueen's Reply
por: Macqueen, J. Gordon
Publicado: (1913)

Reply: cost-effectiveness of population-based screening for colorectal cancer
por: Sharp, L, et al.
Publicado: (2013)

REPLY FROM DR. STEPHEN M. SAGAR
por: Sagar, Stephen M.
Publicado: (2007)

Authors' Reply to Comments from Dr. Guan
por: Inoue, Ken-ichiro, et al.
Publicado: (2009)

Trichomoniasis: An update
por: Preethi, V, et al.
Publicado: (2011)

Vaginal trichomoniasis
por: Cenkowski, Monica, et al.
Publicado: (2022)

Dr. Purves Stewart's Reply
Publicado: (1907)

Reply to Dr. Takeuchi: PRES after epidural anesthesia
por: Pugliese, Silvia, et al.
Publicado: (2011)

Reply to the letter from Dr. Miao et al.
por: Tanimura, Yuko, et al.
Publicado: (2016)

Reply to: Balancing Cost and Efficiency in Screening Potential Organ Donors With Whole Body CT
por: Mensink, Jacobus W., et al.
Publicado: (2020)

Reply to Dr. de Kernagal’s Letter to the Editor “FAST and undertriage”
por: Lubbers, Wouter D., et al.
Publicado: (2010)

Reply to the letter from Dr. Pirjo Pärnänen et al
por: Bose, Mukulika, et al.
Publicado: (2021)

Reply to: Comments on “Finding the optimal mammography screening strategy: A cost‐effectiveness analysis of 920 modeled strategies”
por: Kregting, Lindy M., et al.
Publicado: (2022)

Severe rhabdomyolysis and SARS-CoV-2 vaccination: a reply to the letter by Dr. Josef Finsterer.: Reply to Letter to the Editor regarding our report to Dr. Finsterer.
por: Kamura, Yuya, et al.
Publicado: (2022)

Reply: CIITA methylation and decreased levels of HLA-DR in tumour progression
por: Morimoto, Y, et al.
Publicado: (2004)

Oestrogen receptors in primary breast cancer: Dr. Alanko and colleagues reply
por: Alanko, A., et al.
Publicado: (1985)

Lymphoid infiltration and prognosis in colorectal carcinoma: Dr. Sevennevig & Colleagues reply
por: Svennevig, J.L., et al.
Publicado: (1984)

Reply to Dr. Tourtier’s Letter to the Editor “Human errors in (inhuman?) triage”
por: Giannakopoulos, Georgios F., et al.
Publicado: (2010)

Prevalence of Trichomoniasis by PCR in Women Attending Health Screening in Korea
por: Kim, Seung-Ryong, et al.
Publicado: (2016)

Reply: Flawed methods explain the effect of mammography screening in Nijmegen
por: Verbeek, A L M, et al.
Publicado: (2011)

Trichomoniasis and Lactoferrin: Future Prospects
por: Sehgal, Rakesh, et al.
Publicado: (2012)

Comparison of assays used for in vitro chemosensitivity testing of human tumours: Dr Wilson replies
por: Wilson, A.P.
Publicado: (1984)

Reply: The value of case–control audits of screening
por: Sasieni, P, et al.
Publicado: (2004)

Reply: Screening for colorectal cancer with immunological FOBT
por: Saito, Hiroshi, et al.
Publicado: (2004)

2669. Improving Trichomoniasis Screening Among Cis- and Transgender Women with HIV
por: Igwe, Nnamdi, et al.
Publicado: (2023)

Reply to comments and questions of Dr. Correale et al. about our review concerning CTEPH
por: Schölzel, Bastiaan E., et al.
Publicado: (2015)

Dr. Chandrasekaran’s reply to “Exercising and face masks: An important hypothesis buried in a selective review”
por: Chandrasekaran, Baskaran, et al.
Publicado: (2020)

Reply: Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?
por: Rosario, D J, et al.
Publicado: (2013)

Trichomonas vaginalis, HIV, and African-Americans.
por: Sorvillo, F, et al.
Publicado: (2001)

Trichomoniasis immunity and the involvement of the purinergic signaling
por: Menezes, Camila Braz, et al.
Publicado: (2016)

Vitamin D supplementation and COVID-19 disease: safety but unproven efficacy—reply to Dr Helga Rhein
por: Harvey, Nicholas C., et al.
Publicado: (2021)

Thermal Death Point of Baylisascaris procyonis Eggs
por: Shafir, Shira C., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_4bf3shsd7ashd15r2478ja8f7m